| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Morphology, University Medical Center, CH-1211 Geneva 4, Switzerland [R. M., J. V. S., G. H., M. S. P.], and Department of Physiology, University of Innsbruck, A-6020 Innsbruck, Austria [H. S.]
During certain developmental processes, as well as during tumor progression, polarized epithelial cells integrated within multicellular structures convert into scattered, freely migrating fibroblast-like cells. Despite the biological and clinical importance of this phenomenon, the intracellular biochemical cascades that control the switch between the epithelial and mesenchymal phenotypes have not been elucidated. Using Madin-Darby canine kidney (MDCK) cells (clone C7) as a model system, we have assessed the potential role of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) cascade in the modulation of epithelial plasticity. When grown in three-dimensional collagen gels, MDCK-C7 cells form spherical cysts composed of polarized epithelial cells circumscribing a central lumen. This morphogenetic behavior is profoundly subverted in MDCK-C7 cells expressing a constitutively active MAPK/ERK kinase 1 (caMEK1) mutant (C7-caMEK1 cells). When suspended in collagen gels, C7-caMEK1 cells assume an elongated fibroblastoid shape and are unable to generate multicellular cysts. In addition, when seeded onto the surface of a collagen gel, C7-caMEK1 cells penetrate extensively into the underlying matrix, unlike wild-type and mock-transfected MDCK-C7 cells, which remain confined to the surface of the gel. Similar changes in morphogenetic and invasive properties are observed in MDCK-C7F cells, a nontransfected, stably dedifferentiated derivative of MDCK-C7 cells that expresses substantially increased ERK2 activity. Both C7-caMEK1 and MDCK-C7F cells but not wild-type or mock-transfected MDCK-C7 cells express activated Mr 72,000 gelatinase A [matrix metalloproteinase (MMP)-2] as well as elevated levels of membrane type-1 MMP. Synthetic MMP inhibitors as well as recombinant tissue inhibitor of metalloproteinases 2 and 3 suppress the invasion of collagen gels and restore the capacity of C7-caMEK1 cells to form cysts, thereby implicating the membrane type-1 MMP/MMP-2 proteolytic system in epithelial cell invasiveness and loss of multicellular organization. Taken together, our data demonstrate that increased activity of the MEK1-ERK2 signaling module in MDCK-C7 cells is associated with failure of morphogenesis and expression of a highly invasive phenotype. Sustained activation of the MAPK cascade therefore results in the destabilization of the three-dimensional architecture and the conversion of polarized epithelial cells into migrating mesenchymal-like cells.
This article has been cited by other articles:
![]() |
V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jorda, D. Olmeda, A. Vinyals, E. Valero, E. Cubillo, A. Llorens, A. Cano, and A. Fabra Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor J. Cell Sci., August 1, 2005; 118(15): 3371 - 3385. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sauvant, H. Holzinger, and M. Gekle Proximal Tubular Toxicity of Ochratoxin A Is Amplified by Simultaneous Inhibition of the Extracellular Signal-Regulated Kinases 1/2 J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 234 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Boyd, J. Doyle, E. Gee, S. Pallan, and T. L. Haas MAPK signaling regulates endothelial cell assembly into networks and expression of MT1-MMP and MMP-2 Am J Physiol Cell Physiol, March 1, 2005; 288(3): C659 - C668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karihaloo, S. Kale, N. D. Rosenblum, and L. G. Cantley Hepatocyte Growth Factor-Mediated Renal Epithelial Branching Morphogenesis Is Regulated by Glypican-4 Expression Mol. Cell. Biol., October 1, 2004; 24(19): 8745 - 8752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pinkas, S. S. Martin, and P. Leder Bcl-2-Mediated Cell Survival Promotes Metastasis of EpH4 {beta}MEKDD Mammary Epithelial Cells Mol. Cancer Res., October 1, 2004; 2(10): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Munshi, Y. I. Wu, S. Mukhopadhyay, A. J. Ottaviano, A. Sassano, J. E. Koblinski, L. C. Platanias, and M. S. Stack Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-{beta}1-induced Pericellular Collagenolysis J. Biol. Chem., September 10, 2004; 279(37): 39042 - 39050. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, X. Cai, J. M. Lopez-Guisa, S. J. Collins, and A. A. Eddy Mitogenic Signaling of Urokinase Receptor-Deficient Kidney Fibroblasts: Actions of an Alternative Urokinase Receptor and LDL Receptor-Related Protein J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2090 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.T.T. Nguyen, E. Tran, T.H. Nguyen, P.T. Do, T.H. Huynh, and H. Huynh The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells Carcinogenesis, May 1, 2004; 25(5): 647 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takino, H. Miyamori, Y. Watanabe, K. Yoshioka, M. Seiki, and H. Sato Membrane Type 1 Matrix Metalloproteinase Regulates Collagen-Dependent Mitogen-Activated Protein/Extracellular Signal-Related Kinase Activation and Cell Migration Cancer Res., February 1, 2004; 64(3): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schramek, E. Feifel, I. Marschitz, N. Golochtchapova, G. Gstraunthaler, and R. Montesano Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells Am J Physiol Cell Physiol, September 1, 2003; 285(3): C652 - C661. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Peinado, M. Quintanilla, and A. Cano Transforming Growth Factor {beta}-1 Induces Snail Transcription Factor in Epithelial Cell Lines: MECHANISMS FOR EPITHELIAL MESENCHYMAL TRANSITIONS J. Biol. Chem., May 30, 2003; 278(23): 21113 - 21123. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Bates and A. M. Mercurio Tumor Necrosis Factor-{alpha} Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids Mol. Biol. Cell, May 1, 2003; 14(5): 1790 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Pan and W.-C. Hung Nonsteroidal Anti-inflammatory Drugs Inhibit Matrix Metalloproteinase-2 via Suppression of the ERK/Sp1-mediated Transcription J. Biol. Chem., August 30, 2002; 277(36): 32775 - 32780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pinkas and P. Leder MEK1 Signaling Mediates Transformation and Metastasis of EpH4 Mammary Epithelial Cells Independent of an Epithelial to Mesenchymal Transition Cancer Res., August 15, 2002; 62(16): 4781 - 4790. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schramek MAP Kinases: From Intracellular Signals to Physiology and Disease Physiology, April 1, 2002; 17(2): 62 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schulze, K. Lehmann, H. B.J. Jefferies, M. McMahon, and J. Downward Analysis of the transcriptional program induced by Raf in epithelial cells Genes & Dev., April 15, 2001; 15(8): 981 - 994. [Abstract] [Full Text] |
||||
![]() |
A. Zubilewicz, C. Hecquet, J.-C. Jeanny, G. Soubrane, Y. Courtois, and F. Mascarelli Proliferation of CECs Requires Dual Signaling through Both MAPK/ERK and PI 3-K/Akt Pathways Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 488 - 496. [Abstract] [Full Text] |
||||
![]() |
H. Reuveni, T. Geiger, B. Geiger, and A. Levitzki Reversal of the Ras-induced Transformed Phenotype by HR12, a Novel Ras Farnesylation Inhibitor, Is Mediated by the Mek/Erk Pathway J. Cell Biol., December 11, 2000; 151(6): 1179 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Marschitz, J. Lechner, I. Mosser, M. Dander, R. Montesano, and H. Schramek Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1472 - C1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hotary, E. Allen, A. Punturieri, I. Yana, and S. J. Weiss Regulation of Cell Invasion and Morphogenesis in a Three-dimensional Type I Collagen Matrix by Membrane-type Matrix Metalloproteinases 1, 2, and 3 J. Cell Biol., June 12, 2000; 149(6): 1309 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gekle, G. Schwerdt, R. Freudinger, S. Mildenberger, D. Wilflingseder, V. Pollack, M. Dander, and H. Schramek Ochratoxin A Induces JNK Activation and Apoptosis in MDCK-C7 Cells at Nanomolar Concentrations J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 837 - 844. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |